Human KNG1 protein (Recombinant) (N-His) (STJP003512)

SKU:
STJP003512
€250.20 - €1,396.20
Free Shipping
Processing The item has been added

Short Description :Recombinant-Human KNG1-N-His protein was developed from e.coli for the region N-His. For use in research applications.
Applications:ELISA/Immunogen/SDS-PAGE/WB
Host:E.coli
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Dilution Range:Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Formulation:Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Storage Instruction:Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at-20 to-80°C for twelve months from the date of receipt.
Gene Symbol:KNG1
Gene ID:3827
Uniprot ID:KNG1_HUMAN
Immunogen:Homo sapiens (Human)
Immunogen Region:Arg58-Leu176
Post Translational Modifications Bradykinin: Bradykinin is inactivated by ACE, which removes the dipeptide Arg-Phe from its C-terminus. Bradykinin is released from kininogen by plasma kallikrein. Hydroxylation of Pro-383 occurs prior to the release of bradykinin. Phosphorylated by FAM20C in the extracellular medium. N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. (Microbial infection) Bradykinin is generated upon proteolytic cleavage by S.pyogenes SpeB to produce hypotension during septic shock.
Function Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII.HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting. Bradykinin: The active peptide bradykinin is a potent vasodilatator that is released from HMW-kininogen shows a variety of physiological effects: (A) influence in smooth muscle contraction, (B) induction of hypotension, (C) natriuresis and diuresis, (D) decrease in blood glucose level, (E) it is a mediator of inflammation and causes (E1) increase in vascular permeability, (E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action).
Protein Name Kininogen-1
Alpha-2-Thiol Proteinase Inhibitor
Fitzgerald Factor
High Molecular Weight Kininogen
Hmwk
Williams-Fitzgerald-Flaujeac Factor Cleaved Into - Kininogen-1 Heavy Chain - T-Kinin
Ile-Ser-Bradykinin - Bradykinin
Kallidin I - Lysyl-Bradykinin
Kallidin Ii - Kininogen-1 Light Chain - Low Molecular Weight Growth-Promoting Factor
Database Links Reactome: R-HSA-114608
Reactome: R-HSA-140837
Reactome: R-HSA-375276
Reactome: R-HSA-381426
Reactome: R-HSA-416476
Reactome: R-HSA-418594
Reactome: R-HSA-8957275
Cellular Localisation Secreted
Extracellular Space
Alternative Protein Names Kininogen-1 protein
Alpha-2-Thiol Proteinase Inhibitor protein
Fitzgerald Factor protein
High Molecular Weight Kininogen protein
Hmwk protein
Williams-Fitzgerald-Flaujeac Factor Cleaved Into - Kininogen-1 Heavy Chain - T-Kinin protein
Ile-Ser-Bradykinin - Bradykinin protein
Kallidin I - Lysyl-Bradykinin protein
Kallidin Ii - Kininogen-1 Light Chain - Low Molecular Weight Growth-Promoting Factor protein
KNG1 protein
BDK protein
KNG protein

Information sourced from Uniprot.org